Phase 3 Alopecia Areata Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have agreed to take part and signed a consent form.
- You are Japanese, aged between 18 and 65 years old at the time of signing the consent form, and have severe alopecia areata (significant hair loss condition).
- You have been officially diagnosed with alopecia areata and your current episode of scalp hair loss has been ongoing for at least 6 months.
- Your hair loss has been measured using a specific scoring system (called a SALT score) and the result is 50 or higher at both your initial screening visit and your baseline visit before the trial begins (confirm with trial site).
Who may not be able to join:
- You have taken medications that suppress the immune system — including a type of drug called JAK inhibitors — within the last 4 months.
- You have received a type of treatment called biologics (medicines made from living cells) within the last 6 months.
- Your blood tests at screening showed a positive result for hepatitis B, hepatitis C, or HIV.
- You have a history of active tuberculosis (TB), a positive TB blood test at screening, or signs of TB-related changes seen on a chest X-ray.
- Your screening blood tests showed significant problems with your blood, liver, or kidneys.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of subjects achieving an absolute SALT score of 20 or less
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.